Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SPRY | OCUL | SAVA | ||
| Company | Ars Pharmaceuticals Inc | Ocular Therapeut | Cassava Sciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 13.55 | 8.84 | 26.13 | ||
| High | 13.74 | 8.88 | 33.98 | ||
| Low | 13.01 | 8.21 | 26.03 | ||
| Last | 13.38 | 8.52 | 32.18 | ||
| Change | -0.17 | -0.26 | +6.13 | ||
| % Change | -1.25% | -2.96% | +23.53% | ||
| Volume | 768,700 | 1,085,500 | 4,650,600 | ||
| 20-Day Average Volume | 1,299,905 | 947,635 | 1,629,960 | ||
| Previous Close | 13.55 | 8.78 | 26.05 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 14.97 | 10.28 | 26.61 | ||
| 20-Day Raw Stochastic | 6.73% | 8.70% | 82.91% | ||
| 20-Day Relative Strength | 42.64% | 37.36% | 61.12% | ||
| Weighted Alpha | +130.83 | +142.36 | -0.97 | ||
| Today's Opinion | 56% Buy | 40% Buy | 80% Buy | ||
| Previous Opinion | 56% Buy | 40% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.17% since 11/14/24 | -14.11% since 11/14/24 | +23.11% since 11/14/24 | ||
| Low | 13.01 on 11/21/24 | 8.21 on 11/21/24 | 25.46 on 11/15/24 | ||
| High | 14.38 on 11/15/24 | 10.03 on 11/15/24 | 33.98 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | -19.98% since 10/21/24 | -25.07% since 10/21/24 | +11.43% since 10/21/24 | ||
| Low | 13.01 on 11/21/24 | 8.21 on 11/21/24 | 23.45 on 11/05/24 | ||
| High | 18.51 on 11/11/24 | 11.77 on 10/28/24 | 33.98 on 11/21/24 | ||
| 3-Month | |||||
| %Chg | -0.15% since 08/21/24 | -7.69% since 08/21/24 | +3.11% since 08/21/24 | ||
| Low | 11.00 on 09/06/24 | 8.11 on 09/10/24 | 23.45 on 11/05/24 | ||
| High | 18.51 on 11/11/24 | 11.77 on 10/28/24 | 33.98 on 11/21/24 | ||
| 6-Month | |||||
| %Chg | +51.53% since 05/21/24 | +39.67% since 05/21/24 | +44.50% since 05/21/24 | ||
| Low | 7.55 on 06/25/24 | 4.79 on 06/10/24 | 8.79 on 06/28/24 | ||
| High | 18.51 on 11/11/24 | 11.77 on 10/28/24 | 42.20 on 08/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,316,857 | 1,380,365 | 1,253,266 | ||
| Shares Outstanding, K | 97,185 | 157,217 | 48,110 | ||
| Annual Sales | 30,000 | 58,440,000 | 0 | ||
| Annual Net Income | -54,370,000 | -80,740,000 | -97,220,000 | ||
| Last Quarter Sales | 2,070,000 | 15,430,000 | 0 | ||
| Last Quarter Net Income | -19,130,000 | -36,490,000 | -27,940,000 | ||
| 60-Month Beta | 0.90 | 1.26 | -0.59 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.20 on 11/13/24 | -0.26 on 11/14/24 | -0.58 on 11/07/24 | ||
| Latest Earnings Date | 11/13/24 | 11/14/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | 0.750 on 12/13/12 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||